Zurit Levine
Chief Tech/Sci/R&D Officer bei COMPUGEN LTD.
Profil
Zurit Levine is currently the Vice President-Technology Innovation at Compugen Ltd.
Prior to this role, Dr. Levine held positions as Director at Neviah Genomics Ltd.
and Therapeutic Discovery Corp.
Dr. Levine has an educational background that includes undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
Aktive Positionen von Zurit Levine
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | 01.01.2018 |
Ehemalige bekannte Positionen von Zurit Levine
| Unternehmen | Position | Ende |
|---|---|---|
Therapeutic Discovery Corp.
 Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Director/Board Member | 01.01.2007 |
Neviah Genomics Ltd.
 Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Director/Board Member | - |
Ausbildung von Zurit Levine
| Tel-Aviv University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Health Technology |
Neviah Genomics Ltd.
Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Health Technology |
